ICD-10-CM Billable Code

D75.1

Secondary polycythemia

Clinical Classification Guidelines

Inclusion Terms

  • Acquired polycythemia
  • Emotional polycythemia
  • Erythrocytosis NOS
  • Hypoxemic polycythemia
  • Nephrogenous polycythemia
  • Polycythemia due to erythropoietin
  • Polycythemia due to fall in plasma volume
  • Polycythemia due to high altitude
  • Polycythemia due to stress
  • Polycythemia NOS
  • Relative polycythemia

Excludes Type 1

  • polycythemia neonatorum (P61.1)
  • polycythemia vera (D45)

Medical Intelligence & Overview

Secondary polycythemia, classified under ICD-10 code D75.1, is a condition characterized by an increased number of red blood cells in the bloodstream. Unlike primary polycythemia, which originates from bone marrow disorders, secondary polycythemia is typically a response to other underlying health issues or environmental factors that lead the body to produce more red blood cells. This condition can help the body adapt to low oxygen levels but may also present health challenges if not properly managed.

Causes & Symptoms

Clinical Causes: Chronic hypoxia due to lung diseases such as chronic obstructive pulmonary disease (COPD) or sleep apnea Living at high altitudes where oxygen levels are lower Erythropoietin production triggered by tumors or certain cancers Blood loss or dehydration leading to reduced plasma volume (relative polycythemia) Stress or emotional factors that may stimulate red blood cell production Certain hereditary conditions affecting oxygen sensing Use of performance-enhancing drugs containing erythropoietin

Key Symptoms: Headaches or dizziness Weakness or fatigue Shortness of breath, especially with exertion Reddening of the skin, known as plethora Itching, especially after a hot bath or shower Vision changes or ringing in the ears Night sweats or unexplained weight loss in some cases High blood pressure

Diagnostic & Treatment

Diagnosis Path: Diagnosis of secondary polycythemia involves a combination of medical history, physical examination, and laboratory tests. Blood tests measuring hematocrit and hemoglobin levels help identify increased red blood cell concentration. Additional tests may include erythropoietin level assessments, oxygen saturation measurements, and imaging studies to detect underlying causes such as lung diseases or tumors. Differentiating secondary from primary polycythemia is crucial, often requiring bone marrow examination and genetic testing.

Treatment Protocols: Treatment strategies focus on managing the underlying cause of increased red blood cell production. Approaches may include oxygen therapy for hypoxia-related cases, treating lung or heart conditions, or addressing tumors producing excess erythropoietin. Phlebotomy, or blood removal, might be used in some situations to reduce blood viscosity. Lifestyle modifications, such as quitting smoking and avoiding high altitudes, can also be beneficial. Regular monitoring of blood counts and addressing symptoms are key components of management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D75.1 a billable ICD-10 code?
Yes, D75.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D75.1?
Clinical documentation must specify the nature of Secondary polycythemia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

polycythemia